《中国大动脉炎全病程多学科慢病管理专家共识》 要点解读.

Takayasu arteritis(TAK)is characterized by early onset, long course, high disability rate, and heavy disease burden, which seriously affects the physical and mental health and quality of life of patients. Therefore, it is important to standardize the diagnosis and treatment of TAK and implement comprehensive chronic disease management. However, there are no relevant guidelines or expert consensus so far. Therefore, Professor JIANG Lin-di from the Department of Rheumatology, Zhongshan Hospital，Fudan University has led the development and release of the “Chinese multidisciplinary recommendations on the chronic diseases management throughout the entire course of Takayasu arteritis”, aiming to standardize the diagnosis and treatment process and implement full life cycle management for patients. This article interprets the consensus to facilitate the understanding and application of its essence by clinical physicians in rheumatology and related disciplines. [ABSTRACT FROM AUTHOR]